Medicare Part B spending in four points

It ’s that time of year again when the president releases his budget and questions arise about the solvency of the Medicare trust fund and Medicare spending more generally. Too often, critics point to spending on Medicare Part B medicines as a key driver of Medicare spending, but the data tells a dif ferent story. For example, next month the Medicare Payment Advisory Comission plans to vote on policy proposals that ignore the facts around Medicare Part B, and could harm patient access to both currently marketed and future medicines. 
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare Part B Source Type: news